홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Chloroform → 1-(2-{4-[(6,7-dihydro[1,4]dioxino[2,3-c]pyridazin-3-ylmethyl)amino]-1-piperidinyl}ethyl)-7-(methyloxy)-2(1H)-quinoxalinone dihydrochloride

HRID 656994
인쇄

반응식

HRID 656994 반응식
[NH2:1][CH:2]1[CH2:7][CH2:6][N:5]([CH2:8][CH2:9][N:10]2[C:19]3[C:14](=[CH:15][CH:16]=[C:17]([O:20][CH3:21])[CH:18]=3)[N:13]=[CH:12][C:11]2=[O:22])[CH2:4][CH2:3]1.[N:23]1[C:28]2[O:29][CH2:30][CH2:31][O:32][C:27]=2[CH:26]=[C:25]([CH:33]=O)[N:24]=1.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].C(O[BH3-])(=O)C.C(=O)(O)[O-].[Na+].C(Cl)(Cl)[Cl:60]>CO>[ClH:60].[ClH:60].[N:23]1[C:28]2[O:29][CH2:30][CH2:31][O:32][C:27]=2[CH:26]=[C:25]([CH2:33][NH:1][CH:2]2[CH2:3][CH2:4][N:5]([CH2:8][CH2:9][N:10]3[C:19]4[C:14](=[CH:15][CH:16]=[C:17]([O:20][CH3:21])[CH:18]=4)[N:13]=[CH:12][C:11]3=[O:22])[CH2:6][CH2:7]2)[N:24]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 6

HCID 6212ChloroformHCID 516892Sodium BicarbonateHCID 5049666Sodium triacetoxyborohydrideHCID 12268230AcetoxyborohydrideHCID 248916966,7-Dihydro-[1,4]dioxino[2,3-c]pyridazine-3-carbaldehydeHCID 593978381-[2-(4-Aminopiperidin-1-yl)ethyl]-7-methoxyquinoxalin-2(1H)-one

생성물 1

HCID 68992598
1-(2-{4-[(6,7-dihydro[1,4]dioxino[2,3-c]pyridazin-3-ylmethyl)amino]-1-piperidinyl}ethyl)-7-(methyloxy)-2(1H)-quinoxalinone dihydrochloride
수율 52%

시약·촉매·용매 1

HCID 887Methanol용매

실험 절차

A solution of 1-[2-(4-amino-1-piperidinyl)ethyl]-7-(methyloxy)-2(1H)-quinoxalinone (200 mg; 0.66 mmol) and 6,7-dihydro[1,4]dioxino[2,3-c]pyridazine-3-carbaldehyde (116 mg, 0.70 mmol) in MeOH (8 mL) and chloroform (8 mL) was heated under reflux with 3A molecular sieves overnight. It was cooled and sodium triacetoxyborohydride (0.54 g; 2.55 mmol) was added, and the mixture was stirred at rt overnight. More aldehyde (20 mg) and acetoxyborohydride (100 mg) were added, and this was repeated after 7 h. The mixture was left stirring for three days, then aqueous sodium bicarbonate solution was added to basify and the phases were separated. The aqueous phase was extracted three times with 10% MeOH-DCM, and the organic fractions were dried and evaporated. Chromatography on silica gel, eluting with 0-20% MeOH-DCM gave the free base of the title compound (155 mg, 52%).

후처리

  1. temperatureIt was cooled
  2. waitthis was repeated after 7 h
  3. waitThe mixture was left
  4. stirringstirring for three days
  5. customthe phases were separated
  6. extractionThe aqueous phase was extracted three times with 10% MeOH-DCM
  7. customthe organic fractions were dried
  8. customevaporated
  9. washChromatography on silica gel, eluting with 0-20% MeOH-DCM

출처 및 근거

ORD 기록
ord-ea26dbfe59ac4e9b80b0f5e2527718a2
출처 데이터셋
uspto-grants-2011_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08071592B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트